These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 988175)

  • 1. Effect of dopamine-beta-hydroxylase inhibitors on blood pressure and cardiac norepinephrine levels in rats subjected to immobilization stress.
    Ishii Y; Mimura C; Homma M
    J Pharmacol Exp Ther; 1976 Sep; 198(3):589-95. PubMed ID: 988175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological action of FD-008, a new dopamine-beta-hydroxylase inhibitor. III. Effects on endogenous biogenic amine levels in rats.
    Ishii Y; Homma M; Yoshikawa A; Umezawa H
    Arzneimittelforschung; 1975 Mar; 25(3):383-5. PubMed ID: 1174036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological action of FD-008, a new dopamine beta-hydroxylase inhibitor. I. Effects on blood pressure in rats and dogs.
    Ishii Y; Fujii Y; Mimura Ch; Umezawa H
    Arzneimittelforschung; 1975 Jan; 25(1):55-9. PubMed ID: 1173769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the novel dopamine beta-hydroxylase inhibitor SK&F 102698 on catecholamines and blood pressure in spontaneously hypertensive rats.
    Berkowitz BA; Arleth AJ; Sung CP; Kruse LI; DeWolf WE; Ohlstein EH
    J Pharmacol Exp Ther; 1988 Jun; 245(3):850-7. PubMed ID: 3385645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a dopamine beta-hydroxylase inhibitor on tissue catecholamine levels in spontaneously hypertensive rats subjected to immobilization-cold stress.
    Ishi Y; Homma M; Yoshikawa A
    Neuropharmacology; 1975 Feb; 14(2):155-7. PubMed ID: 1153081
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular effects of a new potent dopamine beta-hydroxylase inhibitor in spontaneously hypertensive rats.
    Ohlstein EH; Kruse LI; Ezekiel M; Sherman SS; Erickson R; DeWolf WE; Berkowitz BA
    J Pharmacol Exp Ther; 1987 May; 241(2):554-9. PubMed ID: 3572812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fusaric (5-butylpicolinic) acid on the monosynaptic reflex neural activity of cat spinal cord.
    Watanabe Y; Matsumiya T; Oka T
    Tokai J Exp Clin Med; 1981 Oct; 6(4):443-51. PubMed ID: 7324082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further characterization of the cardiovascular effects of the dopamine beta-hydroxylase inhibitor SK&F 102698 in conscious hypertensive rats.
    Ohlstein EH; Kruse LI; Ezekiel M; Willette RN
    J Pharmacol Exp Ther; 1988 Oct; 247(1):186-95. PubMed ID: 3050029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain-dependent differences of restraint stress-induced hypertension in WKY and SHR.
    Grundt A; Grundt C; Gorbey S; Thomas MA; Lemmer B
    Physiol Behav; 2009 Jun; 97(3-4):341-6. PubMed ID: 19268675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of dopamine-beta-hydroxylase in the peripheral tissues by 5-dimethyldithiocarbamylpicolinic acid; its effect on stress-induced ulcer, ethanol-induced sleep and blood pressure.
    Hidaka H; Hara F; Harada N; Hashizume Y; Yano M
    J Pharmacol Exp Ther; 1974 Dec; 191(3):384-92. PubMed ID: 4473535
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood pressure decreased by halobutylpicolinic acid, an inhibitor of dopamine beta-hydroxylase.
    Hidaka H; Takeya K
    Nature; 1972 Oct; 239(5371):334-5. PubMed ID: 12635227
    [No Abstract]   [Full Text] [Related]  

  • 12. Tachycardia in spontaneously hypertensive and normotensive rats after fusaric acid and bupicamide.
    Antonaccio MJ; Coté D; Cavaliere T
    Clin Exp Pharmacol Physiol; 1976; 3(3):199-206. PubMed ID: 975616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological action of FD-008, a new dopamine-beta-hydroxylase inhibitor.
    Ishii Y; Natsugoe K; Umezawa H
    Arzneimittelforschung; 1975 Feb; 25(2):213-5. PubMed ID: 1173034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fusaric acid on the membrane potential in left ventricle fragments from rats and rabbits.
    Richter R
    Pharmazie; 1982 Oct; 37(10):736. PubMed ID: 7178221
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolism of 3H-catecholamines in the heart and adrenals of spontaneously hypertensive rats (SHR) after running stress.
    Zukowska-Grójec Z; Wocial B; Chodakowska J; Januszewicz W; Rutczyński M
    Acta Physiol Pol; 1981; 32(2):159-67. PubMed ID: 7270217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCH 10595, an effective dopamine- -hydroxylase inhibitor and a hypotensive agent.
    Korduba CA; Veals J; Wohl A; Symchowicz S; Tabachnick II
    J Pharmacol Exp Ther; 1973 Mar; 184(3):671-7. PubMed ID: 4687230
    [No Abstract]   [Full Text] [Related]  

  • 17. Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: a comparison with hydralazine.
    Velasco M; Gilbert CA; Rutledge CO; McNay JL
    Clin Pharmacol Ther; 1975 Aug; 18(2):145-53. PubMed ID: 1097150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of fusaric acid and its derivative on the cardiovascular system].
    Furuta Y; Washizaki M
    Nihon Yakurigaku Zasshi; 1976 Mar; 72(2):139-44. PubMed ID: 987962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antihypertensive effect of trifluoropentoxypicolinic acid: a pharmacokinetic study].
    Horisaka K; Masuda S
    Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):301-7. PubMed ID: 6745810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.